[The clinical use of levosulpiride in retinal fluorangiography].
The value of administering 25 mg of levosulpiride per os approximately one hour before the sodium fluorescein bolus used in fluorangiography is assessed in order to avoid to the onset of nausea and/or vomiting during and after the test. The study was performed in 35 patients. No nausea and/or vomiting was observed in over 90% of cases treated.
Torrero
M
M
Servizio di Anestesia e Rianimazione, Ospedale Mauriziano Umberto I, Torino.
Rosina
A
A
Paneghel
D
D
Bianchetti
L
L
Fusi
L
L
Vanzetti
M
M
D000328:Adult; D000368:Aged; D019793:Fluorescein; D005451:Fluorescein Angiography; D005452:Fluoresceins / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D011859:Radiography; D012171:Retinal Vessels / Q000000981:diagnostic imaging; D013469:Sulpiride / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D005452:Fluoresceins; D013469:Sulpiride; D019793:Fluorescein
Considerazione sull'uso clinico della levo-sulpiride nella fluorangiografia retinica.